Suppr超能文献

Ⅰ型糖尿病小鼠骨重塑和骨愈合中骨形成 Dickkopf-1 的作用。

Role of osteogenic Dickkopf-1 in bone remodeling and bone healing in mice with type I diabetes mellitus.

机构信息

Department of Medicine III and Center for Healthy Aging, Medical Faculty, Technische Universität Dresden, Fetscherstr. 74, 01307, Dresden, Germany.

Rudolf Schönheimer Institute of Biochemistry, Medical Faculty, University of Leipzig, Johannisallee 30, 04103, Leipzig, Germany.

出版信息

Sci Rep. 2021 Jan 21;11(1):1920. doi: 10.1038/s41598-021-81543-7.

Abstract

Type 1 diabetes mellitus (T1DM) is associated with low bone mass and a higher risk for fractures. Dickkopf-1 (Dkk1), which inhibits Wnt signaling, osteoblast function, and bone formation, has been found to be increased in the serum of patients with T1DM. Here, we investigated the functional role of Dkk1 in T1DM-induced bone loss in mice. T1DM was induced in 10-week-old male mice with Dkk1-deficiency in late osteoblasts/osteocytes (Dkk1;Dmp1-Cre, cKO) and littermate control mice by 5 subsequent injections of streptozotocin (40 mg/kg). Age-matched, non-diabetic control groups received citrate buffer instead. At week 12, calvarial defects were created in subgroups of each cohort. After a total of 16 weeks, weight, fat, the femoral bone phenotype and the area of the bone defect were analyzed using µCT and dynamic histomorphometry. During the experiment, diabetic WT and cKO mice did not gain body weight compared to control mice. Further they lost their perigonadal and subcutaneous fat pads. Diabetic mice had highly elevated serum glucose levels and impaired glucose tolerance, regardless of their Dkk1 levels. T1DM led to a 36% decrease in trabecular bone volume in Cre- negative control animals, whereas Dkk1 cKO mice only lost 16%. Of note, Dkk1 cKO mice were completely protected from T1DM-induced cortical bone loss. T1DM suppressed the bone formation rate, the number of osteoblasts at trabecular bone, serum levels of P1NP and bone defect healing in both, Dkk1-deficient and sufficient, mice. This may be explained by increased serum sclerostin levels in both genotypes and the strict dependence on bone formation for bone defect healing. In contrast, the number of osteoclasts and TRACP 5b serum levels only increased in diabetic control mice, but not in Dkk1 cKO mice. In summary, Dkk1 derived from osteogenic cells does not influence the development of T1DM but plays a crucial role in T1DM-induced bone loss in male mice by regulating osteoclast numbers.

摘要

1 型糖尿病(T1DM)与骨量低和骨折风险增加有关。Dickkopf-1(Dkk1)可抑制 Wnt 信号、成骨细胞功能和骨形成,已在 T1DM 患者的血清中发现其水平升高。在此,我们研究了 Dkk1 在 T1DM 诱导的小鼠骨丢失中的功能作用。通过 5 次连续注射链脲佐菌素(40mg/kg),在 10 周龄雄性小鼠中成骨细胞/成骨细胞晚期(Dkk1;Dmp1-Cre,cKO)和同窝对照小鼠中诱导 1 型糖尿病,年龄匹配的非糖尿病对照组接受柠檬酸缓冲液代替。在第 12 周,对每个队列的亚组进行颅骨缺损。总共 16 周后,使用µCT 和动态组织形态计量学分析体重、脂肪、股骨骨表型和骨缺损面积。在实验过程中,与对照组相比,糖尿病 WT 和 cKO 小鼠的体重没有增加。此外,它们失去了周围和皮下脂肪垫。无论 Dkk1 水平如何,糖尿病小鼠的血清葡萄糖水平均升高,葡萄糖耐量受损。T1DM 导致 Cre-阴性对照动物的小梁骨体积减少 36%,而 Dkk1 cKO 小鼠仅减少 16%。值得注意的是,Dkk1 cKO 小鼠完全免受 T1DM 诱导的皮质骨丢失。T1DM 抑制了骨形成率、小梁骨上成骨细胞的数量、血清 P1NP 水平和两种基因型的骨缺损愈合。这可能是由于两种基因型的血清硬骨素水平升高以及骨形成对骨缺损愈合的严格依赖性所致。相比之下,只有在糖尿病对照小鼠中,而不是在 Dkk1 cKO 小鼠中,破骨细胞数量和 TRACP 5b 血清水平才增加。综上所述,来自成骨细胞的 Dkk1 不会影响 T1DM 的发展,但通过调节破骨细胞数量在 T1DM 诱导的雄性小鼠骨丢失中起关键作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2341/7820472/6f750fb5adf3/41598_2021_81543_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验